Skip to main content

Advertisement

Log in

Brachytherapy in the treatment of breast cancer

  • Review Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Brachytherapy is an important radio-therapeutic modality for a variety of malignancies, including prostate cancer, cervix cancer, breast cancer, vagina cancer, endometrium cancer, head and neck cancer, and many more. This technique has been shown to be an effective and safe non-pharmaceutical treatment with fewer serious complications and better outcome than other treatments for breast cancer. Every year, hundreds of thousands of patients around the world benefit from brachytherapy, which reliably delivers a relatively higher radiation dose to the intended target. However, the follow-up time, patient eligibility criteria, treatment strategy, and radiation doses used in published studies are somewhat inconsistent, making it difficult to strictly compare and evaluate the performance of the treatment. More rigorous studies are required to confirm the safety of this technique and to make outcome data more comparable. In this review, we focus on recent advances in breast brachytherapy techniques and provide an overview of outcomes, cosmetic outcome, toxicity, complications, and limitations of brachytherapy for the treatment of breast cancer. We also summarize the clinical outcomes and toxicity results in patients receiving or not receiving brachytherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ferlay J, Soerjomataram I, Dikshit R et al (2012) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN. Int J Cancer 136:E359–386

    Article  Google Scholar 

  2. Jia M, Zheng R, Zhang S et al (2015) Female breast cancer incidence and mortality in 2011, China. J Thorac Dis 7:1221–1226

    PubMed  PubMed Central  Google Scholar 

  3. Beitsch PD, Hodge CW, Dowlat K et al (2009) The surgeon’s role in breast brachytherapy. Breast J 15:93–100

    Article  PubMed  Google Scholar 

  4. Sarin R (2005) Partial-breast treatment for early breast cancer: emergence of a new paradigm. Nat Clin Pract Oncol 2:40–47

    Article  PubMed  Google Scholar 

  5. Sauer G, Strnad V, Kurzeder C et al (2005) Partial breast irradiation after breast-conserving surgery. Strahlenther Onkol 181:1–8

    Article  PubMed  Google Scholar 

  6. Mille MM, Xu XG, Rivard MJ (2010) Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom. Med Phys 37:662–671

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Fentiman IS, Poole C, Tong D et al (1991) Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer 27:447–450

    Article  CAS  PubMed  Google Scholar 

  8. Fentiman IS, Poole C, Tong D et al (1996) Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 32A:608–611

    Article  CAS  PubMed  Google Scholar 

  9. Vicini FA, Kestin LL, Edmundson GK et al (1999) Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys 45:803–810

    Article  CAS  PubMed  Google Scholar 

  10. Kestin LL, Jaffray DA, Edmundson GK et al (2000) Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys 46:35–43

    Article  CAS  PubMed  Google Scholar 

  11. Das RK, Patel R, Shah H et al (2004) 3D CT-based high-dose-rate breast brachytherapy implants: treatment planning and quality assurance. Int J Radiat Oncol Biol Phys 59:1224–1228

    Article  PubMed  Google Scholar 

  12. Major T, Fodor J, Takacsi-Nagy Z et al (2005) Evaluation of HDR interstitial breast implants planned by conventional and optimized CT-based dosimetry systems with respect to dose homogeneity and conformality. Strahlenther Onkol 181:89–96

    Article  PubMed  Google Scholar 

  13. Gloi A, McCourt S, Buchanan R et al (2009) Dosimetric parameters in partial breast irradiation through brachytherapy. Med Dosim 34:207–213

    Article  PubMed  Google Scholar 

  14. Budrukkar A, Gurram L, Upreti RR et al (2015) Clinical outcomes of prospectively treated 140 women with early stage breast cancer using accelerated partial breast irradiation with 3 dimensional computerized tomography based brachytherapy. Radiother Oncol 115:349–354

    Article  PubMed  Google Scholar 

  15. Jolicoeur M, Racine ML, Trop I et al (2011) Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy. Radiother Oncol 100:480–484

    Article  PubMed  Google Scholar 

  16. Mast M, Coerkamp E, Heijenbrok M et al (2014) Target volume delineation in breast conserving radiotherapy: are co-registered CT and MR images of added value? Radiat Oncol 9:65

    Article  PubMed  PubMed Central  Google Scholar 

  17. Poulin E, Gardi L, Barker K et al (2015) Validation of a novel robot-assisted 3DUS system for real-time planning and guidance of breast interstitial HDR brachytherapy. Med Phys 42:6830–6839

    Article  PubMed  Google Scholar 

  18. Wazer DE, Berle L, Graham R et al (2002) Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 53:889–897

    Article  PubMed  Google Scholar 

  19. Ott OJ, Potter R, Hammer J et al (2004) Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German–Austrian multicenter trial. Strahlenther Onkol 180:642–649

    Article  PubMed  Google Scholar 

  20. Benitez PR, Chen PY, Vicini FA et al (2004) Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy. Am J Surg 188:355–364

    Article  PubMed  Google Scholar 

  21. Strnad V, Ott O, Potter R et al (2004) Interstitial brachytherapy alone after breast conserving surgery: interim results of a German-Austrian multicenter phase II trial. Brachytherapy 3:115–119

    Article  PubMed  Google Scholar 

  22. Hannoun-Levi JM, Houvenaeghel G, Ellis S et al (2004) Partial breast irradiation as second conservative treatment for local breast cancer recurrence. Int J Radiat Oncol Biol Phys 60:1385–1392

    Article  PubMed  Google Scholar 

  23. Wazer DE, Kaufman S, Cuttino L et al (2006) Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 64:489–495

    Article  PubMed  Google Scholar 

  24. Nose T, Komoike Y, Yoshida K et al (2006) A pilot study of wider use of accelerated partial breast irradiation: intraoperative margin-directed re-excision combined with sole high-dose-rate interstitial brachytherapy. Breast Cancer 13:289–299

    Article  PubMed  Google Scholar 

  25. Chen PY, Vicini FA, Benitez P et al (2006) Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 106:991–999

    Article  PubMed  Google Scholar 

  26. Yoshida K, Nose T, Masuda N et al (2009) Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Breast Cancer 16:105–112

    Article  PubMed  Google Scholar 

  27. Johansson B, Karlsson L, Liljegren G et al (2009) Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-T2 breast cancer: first long time results from a clinical study. Radiother Oncol 90:30–35

    Article  PubMed  Google Scholar 

  28. Polgar C, Major T, Fodor J et al (2010) Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 94:274–279

    Article  PubMed  Google Scholar 

  29. Yeo SG, Kim J, Kwak GH et al (2010) Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: local control and toxicity. Radiat Oncol 5:56

    Article  PubMed  PubMed Central  Google Scholar 

  30. Strnad V, Hildebrandt G, Potter R et al (2011) Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys 80:17–24

    Article  PubMed  Google Scholar 

  31. Kauer-Dorner D, Potter R, Resch A et al (2012) Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother Oncol 102:96–101

    Article  PubMed  Google Scholar 

  32. Shah C, McGee M, Wilkinson JB et al (2012) Clinical outcomes using accelerated partial breast irradiation in patients with ductal carcinoma in situ. Clin Breast Cancer 12:259–263

    Article  PubMed  Google Scholar 

  33. Hannoun-Levi JM, Resch A, Gal J et al (2013) Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol 108:226–231

    Article  PubMed  Google Scholar 

  34. Kamrava M, Kuske RR, Anderson B et al (2015) Outcomes of breast cancer patients treated with accelerated partial breast irradiation via multicatheter interstitial brachytherapy: the Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience. Ann Surg Oncol 22[Suppl 3]:404–411

    Article  Google Scholar 

  35. Lovey K, Fodor J, Major T et al (2007) Fat necrosis after partial-breast irradiation with brachytherapy or electron irradiation versus standard whole-breast radiotherapy–4-year results of a randomized trial. Int J Radiat Oncol Biol Phys 69:724–731

    Article  PubMed  Google Scholar 

  36. Antonucci JV, Wallace M, Goldstein NS et al (2009) Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys 74:447–452

    Article  PubMed  Google Scholar 

  37. Wadasadawala T, Sarin R, Budrukkar A et al (2009) Accelerated partial-breast irradiation vs conventional whole-breast radiotherapy in early breast cancer: a case-control study of disease control, cosmesis, and complications. J Cancer Res Ther 5:93–101

    Article  PubMed  Google Scholar 

  38. Shah C, Antonucci JV, Wilkinson JB et al (2011) Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis. Radiother Oncol 100:210–214

    Article  PubMed  Google Scholar 

  39. Ferraro DJ, Garsa AA, DeWees TA et al (2012) Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation. Radiat Oncol 7:53

    Article  PubMed  PubMed Central  Google Scholar 

  40. Strnad V, Ott OJ, Hildebrandt G et al (2016) 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 387:229–238

    Article  PubMed  Google Scholar 

  41. Perrucci E, Lancellotta V, Bini V et al (2015) Quality of life and cosmesis after breast cancer: whole breast radiotherapy vs partial breast high-dose-rate brachytherapy. Tumori 101:161–167

    Article  PubMed  Google Scholar 

  42. Bodacs I, Polgar C, Major T (2014) Dosimetric comparison of external partial breast irradiation with whole breast irradiation and partial breast brachytherapy. Magy Onkol 58:108–115

    PubMed  Google Scholar 

  43. Chan TY, Tan PW, Tan CW et al (2015) Assessing radiation exposure of the left anterior descending artery, heart and lung in patients with left breast cancer: a dosimetric comparison between multicatheter accelerated partial breast irradiation and whole breast external beam radiotherapy. Radiother Oncol 117:459–466

    Article  PubMed  Google Scholar 

  44. Anbumani S, Palled SR, Prabhakar GS et al (2012) Accelerated partial breast irradiation using external beam radiotherapy-A feasibility study based on dosimetric analysis. Rep Pract Oncol Radiother 17:200–206

    Article  PubMed  PubMed Central  Google Scholar 

  45. Roy S, Devleena Maji T et al (2013) Tumor bed boost in breast cancer: brachytherapy versus electron beam. Indian J Med Paediatr Oncol 34:257–263

    Article  PubMed  PubMed Central  Google Scholar 

  46. Shah C, Khwaja S, Badiyan S et al (2013) Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis. Brachytherapy 12:278–284

    Article  PubMed  Google Scholar 

  47. Patel PS, Yan W, Trichter S et al (2011) Seroma is an expected consequence and not a complication of MammoSite brachytherapy. Breast J 17:498–502

    Article  PubMed  Google Scholar 

  48. Ravi A, Lee S, Karsif K et al (2010) Intraoperative placement of MammoSite for breast brachytherapy treatment and seroma incidence. Brachytherapy 9:76–80

    Article  PubMed  Google Scholar 

  49. Shaitelman SF, Vicini FA, Beitsch P et al (2010) Five-year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite Registry Trial. Cancer 116:4677–4685

    Article  PubMed  Google Scholar 

  50. Beitsch P, Vicini F, Keisch M et al (2010) Five-year outcome of patients classified in the “unsuitable” category using the American Society of Therapeutic Radiology and Oncology (ASTRO) Consensus Panel guidelines for the application of accelerated partial breast irradiation: an analysis of patients treated on the American Society of Breast Surgeons MammoSite(R) Registry trial. Ann Surg Oncol 17[Suppl 3]:219–225

    Article  PubMed  Google Scholar 

  51. Aburabia M, Roses RE, Kuerer HM et al (2011) Axillary failure in patients treated with MammoSite accelerated partial breast irradiation. Ann Surg Oncol 18:3415–3421

    Article  PubMed  Google Scholar 

  52. Shah C, Vicini F, Keisch M et al (2012) Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation. Cancer 118:4126–4131

    Article  PubMed  Google Scholar 

  53. Khan AJ, Vicini FA, Beitsch P et al (2012) Local control, toxicity, and cosmesis in women > 70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Int J Radiat Oncol Biol Phys 84:323–330

    Article  PubMed  Google Scholar 

  54. Shah C, Badiyan S, Ben Wilkinson J et al (2013) Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite((R)) breast brachytherapy registry trial. Ann Surg Oncol 20:3279–3285

    Article  PubMed  Google Scholar 

  55. Zauls AJ, Watkins JM, Wahlquist AE et al (2012) Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups. Int J Radiat Oncol Biol Phys 82:21–29

    Article  PubMed  Google Scholar 

  56. Beitsch PD, Wilkinson JB, Vicini FA et al (2012) Tumor bed control with balloon-based accelerated partial breast irradiation: incidence of true recurrences versus elsewhere failures in the American Society of Breast Surgery MammoSite((R)) Registry Trial. Ann Surg Oncol 19:3165–3170

    Article  PubMed  Google Scholar 

  57. Shah C, Wilkinson JB, Lyden M et al (2012) Comparison of survival and regional failure between accelerated partial breast irradiation and whole breast irradiation. Brachytherapy 11:311–315

    Article  PubMed  Google Scholar 

  58. Sher DJ, Wittenberg E, Suh WW et al (2009) Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys 74:440–446

    Article  PubMed  Google Scholar 

  59. Rivera R, Banks A, Casillas-Lopez A et al (2016) Targeted intraoperative radiotherapy for the management of ductal carcinoma in situ of the breast. Breast J 22:63–74

    Article  PubMed  Google Scholar 

  60. Trifiletti DM, Romano KD, Showalter SL et al (2015) Accelerated partial breast irradiation with brachytherapy: patient selection and technique considerations. Breast Cancer 7:211–221

    PubMed  PubMed Central  Google Scholar 

  61. Shah C, Wilkinson JB, Lyden M et al (2012) Predictors of local recurrence following accelerated partial breast irradiation: a pooled analysis. Int J Radiat Oncol Biol Phys 82:e825–830

    Article  PubMed  Google Scholar 

  62. Wilder RB, Curcio LD, Khanijou RK et al (2010) Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status. Int J Radiat Oncol Biol Phys 78:799–803

    Article  PubMed  Google Scholar 

  63. Khan AJ, Vicini F, Beitsch P et al (2009) Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial. Ann Surg Oncol 16:1612–1618

    Article  CAS  PubMed  Google Scholar 

  64. Kaufman SA, Dipetrillo TA, Ruthazer R et al (2005) MammoSite excision volume as a predictor for residual disease. Cancer 104:906–912

    Article  PubMed  Google Scholar 

  65. Dragun AE, Harper JL, Jenrette JM et al (2007) Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys 68:354–358

    Article  PubMed  Google Scholar 

  66. Goyal S, Khan AJ, Vicini F et al (2009) Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial. Ann Surg Oncol 16:2450–2458

    Article  PubMed  Google Scholar 

  67. Watkins JM, Harper JL, Dragun AE et al (2008) Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy 7:305–309

    Article  PubMed  PubMed Central  Google Scholar 

  68. Vicini FA, Keisch M, Shah C et al (2012) Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. Int J Radiat Oncol Biol Phys 83:512–518

    Article  PubMed  Google Scholar 

  69. Shah C, Wilkinson JB, Keisch M et al (2013) Impact of margin status on outcomes following accelerated partial breast irradiation using single-lumen balloon-based brachytherapy. Brachytherapy 12:91–98

    Article  PubMed  Google Scholar 

  70. Vicini FA, Beitsch PD, Quiet CA et al (2005) First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 104:1138–1148

    Article  PubMed  Google Scholar 

  71. Haffty BG, Vicini FA, Beitsch P et al (2008) Timing of chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Int J Radiat Oncol Biol Phys 72:1441–1448

    Article  PubMed  Google Scholar 

  72. Hepel JT, Hiatt JR, Cardarelli GA et al (2010) Modeling study for optimization of skin dose for partial breast irradiation using Xoft Axxent electronic brachytherapy applicator. Brachytherapy 9:81–85

    Article  PubMed  Google Scholar 

  73. Dickler A, Kirk MC, Seif N et al (2007) A dosimetric comparison of MammoSite high-dose-rate brachytherapy and Xoft Axxent electronic brachytherapy. Brachytherapy 6:164–168

    Article  PubMed  Google Scholar 

  74. Cifter G, Chin J, Cifter F et al (2015) Targeted radiotherapy enhancement during electronic brachytherapy of accelerated partial breast irradiation (APBI) using controlled release of gold nanoparticles. Phys Med 31:1070–1074

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Chen SS, Strauss JB, Shah AP et al (2009) Radiation recall reaction with docetaxel administration after accelerated partial breast irradiation with electronic brachytherapy. Brachytherapy 8:331–334

    Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Program of Hebei Administration of Traditional Chinese Medicine (2013031).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jianhui Cai.

Ethics declarations

Conflict of interest

All authors declare that they have no conflicts of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deng, X., Wu, H., Gao, F. et al. Brachytherapy in the treatment of breast cancer. Int J Clin Oncol 22, 641–650 (2017). https://doi.org/10.1007/s10147-017-1155-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-017-1155-5

Keywords

Navigation